MYD88 and colorectal carcinoma: Nevertheless, a recent report demonstrated that MyD88-deficient mice, similar to NLRX1−/− mice, exhibited resistance to CRC in an AOM model and increased susceptibility to AOM/DSS-induced carcinogenesis associated with increased apoptosis induced by DSS alone (17).